GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (STU:MED) » Definitions » Cash Ratio

MediClin AG (STU:MED) Cash Ratio : 0.67 (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is MediClin AG Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. MediClin AG's Cash Ratio for the quarter that ended in Jun. 2024 was 0.67.

MediClin AG has a Cash Ratio of 0.67. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for MediClin AG's Cash Ratio or its related term are showing as below:

STU:MED' s Cash Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.53   Max: 0.77
Current: 0.67

During the past 13 years, MediClin AG's highest Cash Ratio was 0.77. The lowest was 0.17. And the median was 0.53.

STU:MED's Cash Ratio is ranked better than
55.89% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 0.56 vs STU:MED: 0.67

MediClin AG Cash Ratio Historical Data

The historical data trend for MediClin AG's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG Cash Ratio Chart

MediClin AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.59 0.56 0.52 0.67

MediClin AG Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.70 0.67 0.64 0.67

Competitive Comparison of MediClin AG's Cash Ratio

For the Medical Care Facilities subindustry, MediClin AG's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG's Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Cash Ratio distribution charts can be found below:

* The bar in red indicates where MediClin AG's Cash Ratio falls into.



MediClin AG Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

MediClin AG's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=115.286/171.239
=0.67

MediClin AG's Cash Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash Ratio (Q: Jun. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=122.691/183.435
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediClin AG  (STU:MED) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


MediClin AG Cash Ratio Related Terms

Thank you for viewing the detailed overview of MediClin AG's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MediClin AG Business Description

Traded in Other Exchanges
Address
Okenstrasse 27, Offenburg, DEU, 77652
MediClin AG is a company engaged in operating hospitals. The operating segments of the group are Post-acute, Acute, and Other activities. The company generates the majority of its revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.

MediClin AG Headlines

From GuruFocus

Q4 2021 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q3 2022 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q1 2022 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q1 2023 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Jim Simons Adds Medifast Inc to Portfolio in Recent Trade

By GuruFocus Research 02-14-2024

Q4 2023 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-28-2024

Q3 2021 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024